Lexaria Bioscience Corp. (LEXX)
2.88
-0.21
(-6.80%)
USD |
NASDAQ |
Oct 02, 16:00
2.77
-0.11
(-3.82%)
After-Hours: 20:00
Lexaria Bioscience Price : 2.88 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 3.18 | 3.24 | 2.80 | 2.88 | 81261.00 |
| Oct 01, 2026 | 3.20 | 3.25 | 2.95 | 3.09 | 48659.00 |
| Sep 30, 2026 | 3.21 | 3.29 | 3.06 | 3.15 | 23129.00 |
| Sep 29, 2026 | 3.28 | 3.340 | 2.98 | 3.13 | 77524.00 |
| Sep 28, 2026 | 3.25 | 3.460 | 3.15 | 3.225 | 41924.00 |
| Sep 25, 2026 | 3.455 | 3.455 | 3.15 | 3.28 | 34210.00 |
| Sep 24, 2026 | 3.29 | 3.595 | 3.142 | 3.37 | 52964.00 |
| Sep 23, 2026 | 3.31 | 3.34 | 3.10 | 3.235 | 14382.00 |
| Sep 22, 2026 | 3.54 | 3.84 | 3.08 | 3.22 | 107262.0 |
| Sep 21, 2026 | 3.29 | 3.48 | 3.15 | 3.425 | 25962.00 |
| Sep 18, 2026 | 3.25 | 3.52 | 3.15 | 3.24 | 76321.00 |
| Sep 17, 2026 | 3.07 | 4.00 | 2.91 | 3.29 | 164311.0 |
| Sep 16, 2026 | 3.28 | 3.47 | 2.800 | 3.095 | 150397.0 |
| Sep 15, 2026 | 3.54 | 3.932 | 2.98 | 3.21 | 123675.0 |
| Sep 14, 2026 | 3.98 | 4.15 | 3.14 | 3.55 | 178913.0 |
| Sep 11, 2026 | 4.15 | 4.72 | 3.645 | 3.97 | 197057.0 |
| Sep 10, 2026 | 7.00 | 7.50 | 4.04 | 4.05 | 226220.0 |
| Sep 09, 2026 | 9.44 | 9.52 | 6.405 | 6.60 | 74405.00 |
| Sep 08, 2026 | 11.09 | 11.09 | 8.81 | 9.37 | 122227.0 |
| Sep 04, 2026 | 12.26 | 14.37 | 12.26 | 14.15 | 22428.00 |
| Sep 03, 2026 | 13.33 | 13.93 | 12.25 | 12.32 | 74765.00 |
| Sep 02, 2026 | 12.63 | 13.61 | 12.40 | 13.20 | 40951.00 |
| Sep 01, 2026 | 11.13 | 12.89 | 11.13 | 12.48 | 65451.00 |
| Aug 31, 2026 | 10.30 | 12.20 | 10.30 | 11.28 | 359550.0 |
| Aug 28, 2026 | 11.42 | 12.48 | 10.35 | 10.35 | 61908.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Target Group, Inc. (Canada) | 0.0007 |
| InMed Pharmaceuticals, Inc. | 1.33 |
| XORTX Therapeutics, Inc. | 1.714 |
| NervGen Pharma Corp. | 1.78 |
| Milestone Pharmaceuticals, Inc. | 0.8097 |
Price Related Metrics
| PS Ratio | 22.31 |
| Price to Book Value | 1.004 |
| Earnings Yield | -183.4% |
| Market Cap | 4.759M |